Discussing 2025 performance, Lyons said the year played out differently than initial expectations, but landed within the company’s organic revenue guidance range of 4% to 6%, finishing at 5.2% organic revenue growth. He said the expert advisory business at Nelson Labs performed worse than expected and became a “pretty significant” headwind. However, that was offset by stronger-than-anticipated volume performance at Sterigenics, which improved more quickly than planned.Lyons also emphasized the company’s fin ...